About Optra SCAN
Optra SCAN is a company based in Sunnyvale (United States) founded in 2012 by Gauri Naik and Abhijeet Gholap. Optra SCAN has raised $30 million across 1 funding round from investors including Molbio Diagnostics. The company has 32 employees as of March 28, 2024. Optra SCAN operates in a competitive market with competitors including Akoya Biosciences, Scopio Labs, PreciPoint, Morphle and Grundium, among others.
- Headquarter Sunnyvale, United States
- Employees 32 as on 28 Mar, 2024
- Founders Gauri Naik, Abhijeet Gholap
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Optrascan India Private Limited
- Date of Incorporation 12 Jun, 2018
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$509.97 K (USD)123.13as on Mar 31, 2022
-
Net Profit
$34.23 K (USD)100.97as on Mar 31, 2022
-
EBITDA
$47.64 K (USD)100.72as on Mar 31, 2022
-
Total Equity Funding
$30 M (USD)
in 1 rounds
-
Latest Funding Round
$30 M (USD), Series B
Nov 15, 2024
- Investors
-
Employee Count
32
as on Mar 28, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Optra SCAN
Optra SCAN has successfully raised a total of $30M through 1 strategic funding round. The most recent funding activity was a Series B round of $30 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Optra SCAN
Optra SCAN has secured backing from 1 investor. Prominent investors backing the company include Molbio Diagnostics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Point-of-care molecular platforms for infectious disease detection are developed.
|
Locked | Locked | Locked |
Investor details for Optra SCAN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Optra SCAN
Investment portfolio details for Optra SCAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Optra SCAN
Detailed financials for Optra SCAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optra Scan Comparisons
Peer comparison for Optra SCAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Optra SCAN
Optra SCAN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akoya Biosciences, Scopio Labs, PreciPoint, Morphle and Grundium, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of solutions for rapid proteomic profiling
|
|
| Locked | Locked | Locked |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| Locked | Locked | Locked |
Digital microscopes and micro-positioning systems are developed.
|
|
| Locked | Locked | Locked |
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
|
|
| Locked | Locked | Locked |
Portable scanning microscopes are supplied for medical researchers.
|
Detailed competitors of Optra SCAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optra Scan
Complete news archive for Optra SCAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Optra SCAN
Optra SCAN was founded in 2012 and raised its 1st funding round 12 years after it was founded.
Optra SCAN is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Gauri Naik is the current CEO of Optra SCAN. They have also founded this company.
Optra SCAN is a funded company, having raised a total of $30M across 1 funding round to date.
As of Mar 28, 2024, the latest employee count at Optra SCAN is 32.
Annual revenue of Optra SCAN is $509.97K as on Mar 31, 2022.
Optra Scan, part of Optra Group of Companies, develops integrated digital pathology solutions. Its flagship product Optra SCAN is an automated whole slide scanner that converts slides into high-resolution digital images. In addition, features such as Optra IMAGE Path, Optra ASSAY, CLOUD Path and Optra TELE Path allows streamlined acquisition, viewing, analysis, conference, share and management of digital pathology images and associated metadata.
Optra SCAN's top competitors include Akoya Biosciences, Scopio Labs and Morphle.
Optra SCAN has 1 investor. Key investors include Molbio Diagnostics.